Hypercalcemia caused by metastatic adamantinoma: Response to radiotherapy

Janice A. Lyons, G. Thomas Budd, Richard L Crownover

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Original languageEnglish
Pages (from-to)33-35
Number of pages3
JournalSarcoma
Volume3
Issue number1
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Adamantinoma
Hypercalcemia
Radiotherapy
Calcium
Parathyroid Hormone
Serum
Radiation
Neoplasm Metastasis
Lung
Neoplasms

ASJC Scopus subject areas

  • Oncology

Cite this

Hypercalcemia caused by metastatic adamantinoma : Response to radiotherapy. / Lyons, Janice A.; Budd, G. Thomas; Crownover, Richard L.

In: Sarcoma, Vol. 3, No. 1, 1999, p. 33-35.

Research output: Contribution to journalArticle

Lyons, Janice A. ; Budd, G. Thomas ; Crownover, Richard L. / Hypercalcemia caused by metastatic adamantinoma : Response to radiotherapy. In: Sarcoma. 1999 ; Vol. 3, No. 1. pp. 33-35.
@article{67f7ec49c88d440fa2d74b15e55650ac,
title = "Hypercalcemia caused by metastatic adamantinoma: Response to radiotherapy",
abstract = "Purpose. To describe successful palliation of a patient with metastatic adamantinoma presenting with lung metastases and hypercalcemia resulting from a parathormone-like substance released from the tumor. Methods and materials. The records of a patient with a history of a tibial adamantinoma who presented with symptoms of hypercalcemia 20 years after the original surgery, as well as the literature concerning hypercalcemia and adamantinoma were reviewed and summarized. Results. After thorough review of the literature we found no prior reports of radiation being used for palliation of hypercalcemia associated with metastatic adamantinoma. We report rapid improvement in symptoms and normalization of serum calcium levels following a course of radiation therapy. The patient remains asymptomatic 15 months following radiotherapy despite a gradual return of elevated serum calcium levels. Discussion. Radiation therapy should be considered as a palliative option for patients who are not surgical candidates presenting with medically refractory hypercalcemia.",
keywords = "Adamantinoma, Hypercalcemia, PTH-like hormone, Radiation",
author = "Lyons, {Janice A.} and Budd, {G. Thomas} and Crownover, {Richard L}",
year = "1999",
doi = "10.1080/13577149977848",
language = "English",
volume = "3",
pages = "33--35",
journal = "Sarcoma",
issn = "1357-714X",
publisher = "Hindawi Publishing Corporation",
number = "1",

}

TY - JOUR

T1 - Hypercalcemia caused by metastatic adamantinoma

T2 - Response to radiotherapy

AU - Lyons, Janice A.

AU - Budd, G. Thomas

AU - Crownover, Richard L

PY - 1999

Y1 - 1999

N2 - Purpose. To describe successful palliation of a patient with metastatic adamantinoma presenting with lung metastases and hypercalcemia resulting from a parathormone-like substance released from the tumor. Methods and materials. The records of a patient with a history of a tibial adamantinoma who presented with symptoms of hypercalcemia 20 years after the original surgery, as well as the literature concerning hypercalcemia and adamantinoma were reviewed and summarized. Results. After thorough review of the literature we found no prior reports of radiation being used for palliation of hypercalcemia associated with metastatic adamantinoma. We report rapid improvement in symptoms and normalization of serum calcium levels following a course of radiation therapy. The patient remains asymptomatic 15 months following radiotherapy despite a gradual return of elevated serum calcium levels. Discussion. Radiation therapy should be considered as a palliative option for patients who are not surgical candidates presenting with medically refractory hypercalcemia.

AB - Purpose. To describe successful palliation of a patient with metastatic adamantinoma presenting with lung metastases and hypercalcemia resulting from a parathormone-like substance released from the tumor. Methods and materials. The records of a patient with a history of a tibial adamantinoma who presented with symptoms of hypercalcemia 20 years after the original surgery, as well as the literature concerning hypercalcemia and adamantinoma were reviewed and summarized. Results. After thorough review of the literature we found no prior reports of radiation being used for palliation of hypercalcemia associated with metastatic adamantinoma. We report rapid improvement in symptoms and normalization of serum calcium levels following a course of radiation therapy. The patient remains asymptomatic 15 months following radiotherapy despite a gradual return of elevated serum calcium levels. Discussion. Radiation therapy should be considered as a palliative option for patients who are not surgical candidates presenting with medically refractory hypercalcemia.

KW - Adamantinoma

KW - Hypercalcemia

KW - PTH-like hormone

KW - Radiation

UR - http://www.scopus.com/inward/record.url?scp=0032968813&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032968813&partnerID=8YFLogxK

U2 - 10.1080/13577149977848

DO - 10.1080/13577149977848

M3 - Article

C2 - 18521262

AN - SCOPUS:0032968813

VL - 3

SP - 33

EP - 35

JO - Sarcoma

JF - Sarcoma

SN - 1357-714X

IS - 1

ER -